Informações:
Falhas:
ID
31510
Descrição
Ezetimibe and Statins on Postprandial Lipemia in Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00699023
Link
https://clinicaltrials.gov/show/NCT00699023
Palavras-chave
Versões (1)
- 30/08/2018 30/08/2018 -
Titular dos direitos
See clinicaltrials.gov
Transferido a
30 de agosto de 2018
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Postprandial Lipemia NCT00699023
Eligibility Postprandial Lipemia NCT00699023
- StudyEvent: Eligibility
Similar models
Eligibility Postprandial Lipemia NCT00699023
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Non-Insulin-Dependent Diabetes Mellitus Disease length
Item
type 2 diabetes since at least two years
boolean
C0011860 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0872146 (UMLS CUI [1,2])
Metabolic Control Stable | Hemoglobin A1c measurement | Diet therapy | Oral hypoglycemic | Other Coding | Metformin
Item
stable metabolic control (hba1c<8.0%) for at least six months on diet or diet+oral hypoglycemic drugs (insulin secretagogues or metformin), not to be changed during the study period.
boolean
C1513158 (UMLS CUI [1,1])
C0205360 (UMLS CUI [1,2])
C0474680 (UMLS CUI [2])
C0012159 (UMLS CUI [3])
C0359086 (UMLS CUI [4])
C3846158 (UMLS CUI [5])
C0025598 (UMLS CUI [6])
C0205360 (UMLS CUI [1,2])
C0474680 (UMLS CUI [2])
C0012159 (UMLS CUI [3])
C0359086 (UMLS CUI [4])
C3846158 (UMLS CUI [5])
C0025598 (UMLS CUI [6])
Body mass index | Stable body weight
Item
bmi<30 kg/m2 and body weight stable during the last six months.
boolean
C1305855 (UMLS CUI [1])
C0517386 (UMLS CUI [2])
C0517386 (UMLS CUI [2])
Gender | Postmenopausal state
Item
both sexes; only post-menopausal women.
boolean
C0079399 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
C0232970 (UMLS CUI [2])
Serum LDL cholesterol measurement | Plasma triglyceride measurement
Item
ldl-cholesterol >130 mg/dl, plasma triglycerides <400 mg/dl.
boolean
C0428474 (UMLS CUI [1])
C0583329 (UMLS CUI [2])
C0583329 (UMLS CUI [2])
Hypolipidemic Agents Absent
Item
no use of hypolipidemic drugs in the last three months.
boolean
C0086440 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,2])
Renal Insufficiency | Creatinine measurement, serum | Hepatic impairment | Elevated serum transaminase levels
Item
patient with renal (serum creatinine >1.5 mg/dl) or hepatic (serum transaminases >three times upper normal values) impairment.
boolean
C1565489 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0948807 (UMLS CUI [3])
C3808571 (UMLS CUI [4])
C0201976 (UMLS CUI [2])
C0948807 (UMLS CUI [3])
C3808571 (UMLS CUI [4])
Cardiovascular Disease
Item
patients with history of cardiovascular disease.
boolean
C0007222 (UMLS CUI [1])
Premenopausal state
Item
pre-menopausal women.
boolean
C0232969 (UMLS CUI [1])
Degenerative disorder | Degenerative disorder chronic
Item
any other acute or chronic degenerative disease.
boolean
C1285162 (UMLS CUI [1])
C1285162 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
C1285162 (UMLS CUI [2,1])
C0205191 (UMLS CUI [2,2])
Anemia | Hemoglobin measurement
Item
anemia (hb<12 g/dl).
boolean
C0002871 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
C0518015 (UMLS CUI [2])
Blood Pressure Uncontrolled
Item
uncontrolled blood pressure.
boolean
C0005823 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,2])
Pharmaceutical Preparations Interfere with Investigational New Drugs
Item
use of any drugs able to interfere with the study medications
boolean
C0013227 (UMLS CUI [1,1])
C0521102 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])
C0521102 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,3])